デフォルト表紙
市場調査レポート
商品コード
1472102

医用画像試薬の世界市場調査&予測、モダリティ別、クラス別、用途別、地域別分析、2023年~2030年

Global Medical Imaging Reagents Market Size study & Forecast, by Modality, by Class, by Application and Regional Analysis, 2023-2030


出版日
ページ情報
英文 200 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
医用画像試薬の世界市場調査&予測、モダリティ別、クラス別、用途別、地域別分析、2023年~2030年
出版日: 2024年04月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医用画像試薬市場は、2022年に約160億米ドルと評価され、予測期間2023年~2030年には6.6%以上の健全な成長率で成長すると予測されています。

試薬は、医療用画像診断の前に患者に投与される特定の物質で、診断目的で内部構造を正確に可視化するのに役立ちます。X線検査中に生成される画像のコントラストを増強するために使用されるこれらの試薬は、病状を正確に診断する上で極めて重要です。さらに、これらの試薬は医療用画像診断法の最適化に貢献し、その正確性と信頼性を保証します。これらのイメージング技術から得られる調査結果は、新薬の市場導入や教育研究の支援に向けた研究開発イニシアチブを推進する上で極めて重要です。個人における可処分所得の増加により、高度なヘルスケアサービスに対する需要が高まっていることから、同市場は長期的に大幅な収益成長を遂げています。さらに、潜在的な消費者に魅力的なインセンティブを提供する政府提供の償還制度も、市場の大幅な収益拡大に寄与しています。

消費者の可処分所得の増加は、先進国と発展途上国の両方において、改善されたヘルスケアサービスに対する需要の増加につながっています。ピーターソン-KFFヘルスシステム・トラッカーによると、2022年、米国の1人当たり医療費は1万2,555米ドルに達し、他の高所得国を4,000米ドル以上上回った。一方、比較可能な国の1人当たり平均医療費は6,651米ドルで、米国の約半分です。新興国の未開拓市場は、市場参入者にとって有利な機会を提供します。特にブラジル、インド、中国などの国々ではヘルスケアとインフラへの投資が増加しており、これらの地域では遺伝子検査の需要が大幅に増加しています。病的な状態に苦しむ患者の人口が急増しているため、根本的な医学的問題を正確に診断するために画像診断技術の利用が必要となり、造影剤市場が大幅に強化されると予想されます。しかし、高度な医用画像試薬の使用は、医療処置の全体的なコストを上昇させ、一般大衆には金銭的に手の届かないものとなっています。低開発国や発展途上国の人々は、関連する高額な費用のために、高度な医療画像サービスを利用することが難しいという課題に直面しています。さらに、画像試薬の不足と低開発国における厳しい政府規制が、予測期間2022-2030年の市場成長を阻害すると予想されています。

医療用画像試薬の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米地域の病院や診断センターの急増が医療用画像試薬市場の成長に大きく貢献したため、北米が2022年の市場を独占しました。さらに、この地域には主要な市場プレーヤーが存在し、市場拡大を促進する重要な要因となっています。北米はまた、予測期間中に大きく成長することが期待されています。これは、北米の大規模な老人人口が医療用画像試薬の成長にとって大きな市場機会を提供しているためです。さらに、政府による高度なヘルスケア施設の提供は、同地域の医療用画像試薬市場の拡大をさらに後押ししています。

本調査の目的は、近年のさまざまなセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の医用画像試薬市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 医用画像試薬の世界市場力学

  • 医用画像試薬市場の影響分析(2020年~2030年)
    • 市場促進要因
      • 消費者の所得水準の向上による充実した医療サービスへの需要
      • クレームによる償還施設と政府からのインセンティブ
    • 市場の課題
      • 医療用試薬による医療費の増加
      • 画像試薬の入手不可能性と政府による厳しい規制
    • 市場機会
      • 新興国における未開拓市場
      • 世界の患者の病的状態の増加

第4章 世界の画像診断試薬市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 医用画像試薬の世界市場:モダリティ別

  • 市場スナップショット
  • 医用画像試薬の世界市場:モダリティ別、実績 - ポテンシャル分析
  • 医用画像試薬の世界市場:モダリティ別推定・予測:2020年~2030年
  • 医用画像試薬市場、サブセグメント別分析
    • X線
    • CTスキャン
    • 超音波検査
    • MRIスキャン

第6章 医用画像試薬の世界市場:クラス別

  • 市場スナップショット
  • 医用画像試薬の世界市場:クラス別、実績 - ポテンシャル分析
  • 医用画像試薬の世界市場:クラス別推定・予測、2020年~2030年
  • 医用画像試薬市場、サブセグメント別分析
    • 造影試薬
    • 光学試薬
    • 核試薬

第7章 医用画像試薬の世界市場:用途別

  • 市場スナップショット
  • 医用画像試薬の世界市場:用途別、実績 - ポテンシャル分析
  • 医用画像試薬の世界市場、用途別推定・予測、2020年~2030年
  • 医用画像試薬市場、サブセグメント分析
    • 神経疾患
    • 心血管疾患
    • がん
    • 消化器疾患
    • 筋骨格系疾患
    • 腎臓疾患
    • その他

第8章 医用画像試薬の世界市場:地域別分析

  • 主要国
  • 主な新興国
  • 医用画像試薬市場、地域別市場スナップショット
  • 北米
    • 米国
      • モダリティの推定・予測、2020年~2030年
      • クラスの推定・予測、2020年~2030年
      • 用途別の推定・予測、2020年~2030年
    • カナダ
  • 欧州の医用画像試薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の医用画像試薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの医用画像試薬市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Bracco Spa
      • 主要情報
      • 概要
      • 財務(データの入手可能性によります)
      • 製品概要
      • 最近の動向
    • Lantheus Holdings, Inc
    • General Electric Company
    • Siemens AG
    • Bayer AG
    • CMC Contrast AB
    • Thermo Fisher Scientific Inc
    • Merck & Co., Inc
    • Shimadzu Corporation
    • Koninklijke Philips N.V.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Medical Imaging Reagents Market, report scope
  • TABLE 2.Global Medical Imaging Reagents Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3.Global Medical Imaging Reagents Market estimates & forecasts by Modality 2020-2030 (USD Billion)
  • TABLE 4.Global Medical Imaging Reagents Market estimates & forecasts by Class 2020-2030 (USD Billion)
  • TABLE 5.Global Medical Imaging Reagents Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 6.Global Medical Imaging Reagents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Medical Imaging Reagents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Medical Imaging Reagents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Medical Imaging Reagents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Medical Imaging Reagents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Medical Imaging Reagents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Medical Imaging Reagents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Medical Imaging Reagents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Medical Imaging Reagents Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.Global Medical Imaging Reagents Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17.U.S. Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.U.S. Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19.Canada Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20.Canada Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.Canada Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22.UK Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23.UK Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.UK Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25.Germany Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26.Germany Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.Germany Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28.France Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29.France Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.France Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31.Italy Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32.Italy Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Italy Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34.Spain Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35.Spain Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.Spain Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37.RoE Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38.RoE Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.RoE Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40.China Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41.China Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.China Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43.India Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44.India Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.India Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46.Japan Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47.Japan Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.Japan Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49.South Korea Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50.South Korea Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.South Korea Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52.Australia Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53.Australia Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.Australia Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.RoAPAC Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58.Brazil Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59.Brazil Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Brazil Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61.Mexico Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62.Mexico Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.Mexico Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64.RoLA Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65.RoLA Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.RoLA Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67.Saudi Arabia Medical Imaging Reagents Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68.South Africa Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.RoMEA Medical Imaging Reagents Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70.List of secondary sources, used in the study of global Medical Imaging Reagents Market
  • TABLE 71.List of primary sources, used in the study of global Medical Imaging Reagents Market
  • TABLE 72.Years considered for the study
  • TABLE 73.Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Medical Imaging Reagents Market, research methodology
  • FIG 2.Global Medical Imaging Reagents Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Medical Imaging Reagents Market, key trends 2022
  • FIG 5.Global Medical Imaging Reagents Market, growth prospects 2023-2030
  • FIG 6.Global Medical Imaging Reagents Market, porters 5 force model
  • FIG 7.Global Medical Imaging Reagents Market, pest analysis
  • FIG 8.Global Medical Imaging Reagents Market, value chain analysis
  • FIG 9.Global Medical Imaging Reagents Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Medical Imaging Reagents Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Medical Imaging Reagents Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Medical Imaging Reagents Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Medical Imaging Reagents Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Medical Imaging Reagents Market, regional snapshot 2020 & 2030
  • FIG 15.North America Medical Imaging Reagents Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Medical Imaging Reagents Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia pacific Medical Imaging Reagents Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Medical Imaging Reagents Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Medical Imaging Reagents Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Medical Imaging Reagents Market is valued at approximately USD 16 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.6% during the forecast period 2023-2030. The reagent is a particular substance administered to patients prior to medical imaging procedures, aids in the precise visualization of internal structures for diagnostic purposes. Employed to augment contrast in images generated during X-ray examinations, these reagents are pivotal in accurately diagnosing medical conditions. Moreover, they contribute to the optimization of medical imaging procedures, guaranteeing their accuracy and dependability. The results derived from these imaging techniques are pivotal in furthering research and development initiatives, geared towards the introduction of new pharmaceuticals to the market and supporting educational research endeavors. The market has experienced significant revenue growth over time, attributed to rising demand for advanced healthcare services driven by increased disposable income among individuals. Additionally, the market has experienced significant revenue expansion, partly attributed to government-provided reimbursement facilities that provide appealing incentives to potential consumers.

The heightened disposable income of consumers has led to increased demand for improved healthcare services in both developed and developing nations. According to Peterson-KFF Health System Tracker, in 2022, health expenditures per capita in the United States amounted to USD 12,555, surpassing those of any other high-income nation by over USD 4,000. In contrast, the average health expenditure per capita in comparable countries stands at USD 6,651, approximately half of the expenditure in the United States. Untapped emerging markets in developing countries offer lucrative opportunities for market players. Increased investments in healthcare and infrastructure, particularly in countries such as Brazil, India, and China, have led to a significant rise in demand for genetic testing within these regions. The burgeoning population of patients afflicted by pathological conditions is anticipated to significantly bolster the market for contrast agents, as it necessitates the utilization of imaging techniques to accurately diagnose the underlying medical issues. However, the use of sophisticated medical imaging reagents elevates the overall cost of medical procedures, rendering them financially inaccessible to the general populace. Individuals in underdeveloped and developing nations encounter challenges in accessing advanced medical imaging services due to the associated higher costs. Additionally, the lack of imaging reagents and strict government regulations in underdeveloped nations are expected to stifle market growth during the forecast period 2022-2030.

The key regions considered for the Global Medical Imaging Reagents Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the proliferation of hospitals and diagnostic centers in the North American region contributed significantly to the growth of the Medical Imaging Reagents Market. Additionally, the presence of key market players in this geographical area has emerged as a significant factor driving market expansion. North America is also expected to grow significantly over the forecast period, owing to the sizable geriatric population in North America presents a substantial market opportunity for the growth of medical imaging reagents. Moreover, the provision of advanced healthcare facilities by the government further supports the expansion of the Medical Imaging Reagents Market in the region.

Major market player included in this report are:

  • Bracco Spa
  • Lantheus Holdings, Inc
  • General Electric Company
  • Siemens AG
  • Bayer AG
  • CMC Contrast AB
  • Thermo Fisher Scientific Inc
  • Merck & Co., Inc
  • Shimadzu Corporation
  • Koninklijke Philips N.V.

Recent Developments in the Market:

  • In December 2023, Italy-based Bracco Imaging received approval from The European Commission for the market release of Vueway (gadopiclenol), a Gadolinium-Based Contrast Agent (GBCA). Vueway is administered intravenously to enhance contrast in Magnetic Resonance Imaging (MRI) scans.Especially, it contains half the gadolinium dose compared to standard agents.
  • In January 2023, Bayer announced the approval of its iodine-based contrast agents, Ultravist-300 and Ultravist-370, for an extended indication in Contrast-Enhanced Mammography (CEM) through a European Workshare Procedure. CEM is a growing modality integrating digital mammography with contrast agent administration. This strategic expansion enhances Bayer's breast imaging portfolio, encompassing contrast agents and injectors.
  • In April 2022, Thermo Fisher Scientific, a United States-based provider of scientific instrumentation, reagents, consumables, and software services, inaugurated its research and development and engineering facility in Hyderabad, employing 450 engineers and vendor partners.

Global Medical Imaging Reagents Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Modality, Class, Application, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Modality:

  • X-ray
  • CT scan
  • Ultrasound
  • MRI Scan

By Class:

  • Contrast Reagent
  • Optical Reagent
  • Nuclear Reagent

By Application:

  • Neurological Disorder
  • Cardiovascular Disorder
  • Cancer
  • Gastrointestinal Disorder
  • Musculoskeletal Disorder
  • Nephrological Disorder
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Medical Imaging Reagents Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Medical Imaging Reagents Market, by Modality, 2020-2030 (USD Billion)
    • 1.2.3.Medical Imaging Reagents Market, by Class, 2020-2030 (USD Billion)
    • 1.2.4.Medical Imaging Reagents Market, by Application, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Medical Imaging Reagents Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Medical Imaging Reagents Market Dynamics

  • 3.1.Medical Imaging Reagents Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Demand for enhanced medical services due to increased income level of the consumers
      • 3.1.1.2.Reimbursement facilities with claims and incentives from the government
    • 3.1.2.Market Challenges
      • 3.1.2.1.Medical Reagents increase the total cost of the medical treatment
      • 3.1.2.2.Non-Availability of Imaging Reagents and strict regulations from governments
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Untapped market in the developing nations
      • 3.1.3.2.Increasing pathological conditions among the patients globally

Chapter 4.Global Medical Imaging Reagents Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Medical Imaging Reagents Market, by Modality

  • 5.1.Market Snapshot
  • 5.2.Global Medical Imaging Reagents Market by Modality, Performance - Potential Analysis
  • 5.3.Global Medical Imaging Reagents Market Estimates & Forecasts by Modality 2020-2030 (USD Billion)
  • 5.4.Medical Imaging Reagents Market, Sub Segment Analysis
    • 5.4.1.X-ray
    • 5.4.2.CT scan
    • 5.4.3.Ultrasound
    • 5.4.4.MRI Scan

Chapter 6.Global Medical Imaging Reagents Market, by Class

  • 6.1.Market Snapshot
  • 6.2.Global Medical Imaging Reagents Market by Class, Performance - Potential Analysis
  • 6.3.Global Medical Imaging Reagents Market Estimates & Forecasts by Class 2020-2030 (USD Billion)
  • 6.4.Medical Imaging Reagents Market, Sub Segment Analysis
    • 6.4.1.Contrast Reagent
    • 6.4.2.Optical Reagent
    • 6.4.3.Nuclear Reagent

Chapter 7.Global Medical Imaging Reagents Market, by Application

  • 7.1.Market Snapshot
  • 7.2.Global Medical Imaging Reagents Market by Application, Performance - Potential Analysis
  • 7.3.Global Medical Imaging Reagents Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4.Medical Imaging Reagents Market, Sub Segment Analysis
    • 7.4.1.Neurological Disorder
    • 7.4.2.Cardiovascular Disorder
    • 7.4.3.Cancer
    • 7.4.4.Gastrointestinal Disorder
    • 7.4.5.Musculoskeletal Disorder
    • 7.4.6.Nephrological Disorder
    • 7.4.7.Others

Chapter 8.Global Medical Imaging Reagents Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Medical Imaging Reagents Market, Regional Market Snapshot
  • 8.4.North America Medical Imaging Reagents Market
    • 8.4.1.U.S. Medical Imaging Reagents Market
      • 8.4.1.1.Modality breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Class breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Medical Imaging Reagents Market
  • 8.5.Europe Medical Imaging Reagents Market Snapshot
    • 8.5.1.U.K. Medical Imaging Reagents Market
    • 8.5.2.Germany Medical Imaging Reagents Market
    • 8.5.3.France Medical Imaging Reagents Market
    • 8.5.4.Spain Medical Imaging Reagents Market
    • 8.5.5.Italy Medical Imaging Reagents Market
    • 8.5.6.Rest of Europe Medical Imaging Reagents Market
  • 8.6.Asia-Pacific Medical Imaging Reagents Market Snapshot
    • 8.6.1.China Medical Imaging Reagents Market
    • 8.6.2.India Medical Imaging Reagents Market
    • 8.6.3.Japan Medical Imaging Reagents Market
    • 8.6.4.Australia Medical Imaging Reagents Market
    • 8.6.5.South Korea Medical Imaging Reagents Market
    • 8.6.6.Rest of Asia Pacific Medical Imaging Reagents Market
  • 8.7.Latin America Medical Imaging Reagents Market Snapshot
    • 8.7.1.Brazil Medical Imaging Reagents Market
    • 8.7.2.Mexico Medical Imaging Reagents Market
  • 8.8.Middle East & Africa Medical Imaging Reagents Market
    • 8.8.1.Saudi Arabia Medical Imaging Reagents Market
    • 8.8.2.South Africa Medical Imaging Reagents Market
    • 8.8.3.Rest of Middle East & Africa Medical Imaging Reagents Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1. Bracco Spa
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2.Lantheus Holdings, Inc
    • 9.3.3.General Electric Company
    • 9.3.4.Siemens AG
    • 9.3.5.Bayer AG
    • 9.3.6.CMC Contrast AB
    • 9.3.7.Thermo Fisher Scientific Inc
    • 9.3.8.Merck & Co., Inc
    • 9.3.9.Shimadzu Corporation
    • 9.3.10.Koninklijke Philips N.V.

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption